The Genome sequence of the SARS-associated coronavirus - PubMed (original) (raw)
. 2003 May 30;300(5624):1399-404.
doi: 10.1126/science.1085953. Epub 2003 May 1.
Steven J M Jones, Caroline R Astell, Robert A Holt, Angela Brooks-Wilson, Yaron S N Butterfield, Jaswinder Khattra, Jennifer K Asano, Sarah A Barber, Susanna Y Chan, Alison Cloutier, Shaun M Coughlin, Doug Freeman, Noreen Girn, Obi L Griffith, Stephen R Leach, Michael Mayo, Helen McDonald, Stephen B Montgomery, Pawan K Pandoh, Anca S Petrescu, A Gordon Robertson, Jacqueline E Schein, Asim Siddiqui, Duane E Smailus, Jeff M Stott, George S Yang, Francis Plummer, Anton Andonov, Harvey Artsob, Nathalie Bastien, Kathy Bernard, Timothy F Booth, Donnie Bowness, Martin Czub, Michael Drebot, Lisa Fernando, Ramon Flick, Michael Garbutt, Michael Gray, Allen Grolla, Steven Jones, Heinz Feldmann, Adrienne Meyers, Amin Kabani, Yan Li, Susan Normand, Ute Stroher, Graham A Tipples, Shaun Tyler, Robert Vogrig, Diane Ward, Brynn Watson, Robert C Brunham, Mel Krajden, Martin Petric, Danuta M Skowronski, Chris Upton, Rachel L Roper
Affiliations
- PMID: 12730501
- DOI: 10.1126/science.1085953
The Genome sequence of the SARS-associated coronavirus
Marco A Marra et al. Science. 2003.
Abstract
We sequenced the 29,751-base genome of the severe acute respiratory syndrome (SARS)-associated coronavirus known as the Tor2 isolate. The genome sequence reveals that this coronavirus is only moderately related to other known coronaviruses, including two human coronaviruses, HCoV-OC43 and HCoV-229E. Phylogenetic analysis of the predicted viral proteins indicates that the virus does not closely resemble any of the three previously known groups of coronaviruses. The genome sequence will aid in the diagnosis of SARS virus infection in humans and potential animal hosts (using polymerase chain reaction and immunological tests), in the development of antivirals (including neutralizing antibodies), and in the identification of putative epitopes for vaccine development.
Comment in
- Virology. The SARS coronavirus: a postgenomic era.
Holmes KV, Enjuanes L. Holmes KV, et al. Science. 2003 May 30;300(5624):1377-8. doi: 10.1126/science.1086418. Science. 2003. PMID: 12775826 No abstract available.
Similar articles
- Characterization of a novel coronavirus associated with severe acute respiratory syndrome.
Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. Rota PA, et al. Science. 2003 May 30;300(5624):1394-9. doi: 10.1126/science.1085952. Epub 2003 May 1. Science. 2003. PMID: 12730500 - Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China.
Chinese SARS Molecular Epidemiology Consortium. Chinese SARS Molecular Epidemiology Consortium. Science. 2004 Mar 12;303(5664):1666-9. doi: 10.1126/science.1092002. Epub 2004 Jan 29. Science. 2004. PMID: 14752165 - Phylogeny of the SARS coronavirus.
Eickmann M, Becker S, Klenk HD, Doerr HW, Stadler K, Censini S, Guidotti S, Masignani V, Scarselli M, Mora M, Donati C, Han JH, Song HC, Abrignani S, Covacci A, Rappuoli R. Eickmann M, et al. Science. 2003 Nov 28;302(5650):1504-5. doi: 10.1126/science.302.5650.1504b. Science. 2003. PMID: 14645828 No abstract available. - Properties of Coronavirus and SARS-CoV-2.
Malik YA. Malik YA. Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review. - An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development.
Chen S, Luo H, Chen L, Chen J, Shen J, Zhu W, Chen K, Shen X, Jiang H. Chen S, et al. Curr Pharm Des. 2006;12(35):4539-53. doi: 10.2174/138161206779010459. Curr Pharm Des. 2006. PMID: 17168760 Review.
Cited by
- Phase Separation of SARS-CoV-2 Nucleocapsid Protein with TDP-43 Is Dependent on C-Terminus Domains.
Strong MJ, McLellan C, Kaplanis B, Droppelmann CA, Junop M. Strong MJ, et al. Int J Mol Sci. 2024 Aug 12;25(16):8779. doi: 10.3390/ijms25168779. Int J Mol Sci. 2024. PMID: 39201466 Free PMC article. - SARS-CoV-2 aberrantly elevates mitochondrial bioenergetics to induce robust virus propagation.
Shin HJ, Lee W, Ku KB, Yoon GY, Moon HW, Kim C, Kim MH, Yi YS, Jun S, Kim BT, Oh JW, Siddiqui A, Kim SJ. Shin HJ, et al. Signal Transduct Target Ther. 2024 May 11;9(1):125. doi: 10.1038/s41392-024-01836-x. Signal Transduct Target Ther. 2024. PMID: 38734691 Free PMC article. - Effect of Surfactant Therapy on Clinical Outcomes of COVID-19 Patients With ARDS: A Systematic Review and Meta-Analysis.
Mylavarapu M, Dondapati VVK, Dadana S, Sharma DD, Bollu B. Mylavarapu M, et al. Cureus. 2024 Mar 15;16(3):e56238. doi: 10.7759/cureus.56238. eCollection 2024 Mar. Cureus. 2024. PMID: 38618452 Free PMC article. Review. - Broadly neutralizing antibodies against emerging delta-coronaviruses.
Rexhepaj M, Park YJ, Perruzza L, Asarnow D, Mccallum M, Culap K, Saliba C, Leoni G, Balmelli A, Yoshiyama CN, Dickinson MS, Quispe J, Brown JT, Tortorici MA, Sprouse KR, Taylor AL, Starr TN, Corti D, Benigni F, Veesler D. Rexhepaj M, et al. bioRxiv [Preprint]. 2024 Apr 1:2024.03.27.586411. doi: 10.1101/2024.03.27.586411. bioRxiv. 2024. PMID: 38617231 Free PMC article. Preprint. - Benchmarking ANI potentials as a rescoring function and screening FDA drugs for SARS-CoV-2 Mpro.
Zengin IN, Koca MS, Tayfuroglu O, Yildiz M, Kocak A. Zengin IN, et al. J Comput Aided Mol Des. 2024 Mar 27;38(1):15. doi: 10.1007/s10822-024-00554-4. J Comput Aided Mol Des. 2024. PMID: 38532176 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous